K
Kishore Banik
Researcher at Indian Institute of Technology Guwahati
Publications - 58
Citations - 2786
Kishore Banik is an academic researcher from Indian Institute of Technology Guwahati. The author has contributed to research in topics: Cancer & PI3K/AKT/mTOR pathway. The author has an hindex of 24, co-authored 57 publications receiving 1569 citations. Previous affiliations of Kishore Banik include Indian Institutes of Technology.
Papers
More filters
Journal ArticleDOI
Curcumin mediates anticancer effects by modulating multiple cell signaling pathways.
Ajaikumar B. Kunnumakkara,Devivasha Bordoloi,Choudhary Harsha,Kishore Banik,Subash C. Gupta,Bharat B. Aggarwal +5 more
TL;DR: The focus of this review is to discuss the molecular basis for the anticancer activities of curcumin based on preclinical and clinical findings.
Journal ArticleDOI
Chronic diseases, inflammation, and spices: how are they linked?
Ajaikumar B. Kunnumakkara,Bethsebie Lalduhsaki Sailo,Kishore Banik,Choudhary Harsha,Sahdeo Prasad,Subash C. Gupta,Alok C. Bharti,Bharat B. Aggarwal +7 more
TL;DR: The potential of various dietary agents such as spices and its components in the suppression of inflammatory pathways and their roles in the prevention and therapy of cancer and other chronic diseases are discussed.
Journal ArticleDOI
Is curcumin bioavailability a problem in humans: lessons from clinical trials.
Ajaikumar B. Kunnumakkara,Choudhary Harsha,Kishore Banik,Rajesh Vikkurthi,Bethsebie Lalduhsaki Sailo,Devivasha Bordoloi,Subash C. Gupta,Bharat B. Aggarwal +7 more
TL;DR: Over 200 clinical studies with curcumin that have demonstrated the pronounced protective role of this compound against cardiovascular diseases, inflammatory diseases, metabolic diseases, neurological diseases, skin diseases, liver diseases, various types of cancer, etc are discussed.
Journal ArticleDOI
An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases.
Nand Kishor Roy,Dey Parama,Kishore Banik,Devivasha Bordoloi,Amrita Khwairakpam Devi,Krishan Kumar Thakur,Ganesan Padmavathi,Mehdi Shakibaei,Lu Fan,Gautam Sethi,Ajaikumar B. Kunnumakkara +10 more
TL;DR: The present review is an attempt to demonstrate the diverse pharmacological uses of BA, along with its underlying molecular mechanism of action against different ailments, and the roadblocks associated with the pharmacokinetics and bioavailability of this promising compound.
Journal ArticleDOI
FBXW7 in Cancer: What Has Been Unraveled Thus Far?
Bethsebie Lalduhsaki Sailo,Kishore Banik,Sosmitha Girisa,Devivasha Bordoloi,Lu Fan,Clarissa Esmeralda Halim,Hong Wang,Alan Prem Kumar,Dali Zheng,Xinliang Mao,Gautam Sethi,Ajaikumar B. Kunnumakkara +11 more
TL;DR: This comprehensive review emphasizes on the targets, functions, regulators and expression of FBXW7 in different cancers and its involvement in sensitizing cancer cells to chemotherapeutic drugs.